No­vo Nordisk se­cures first two wins in le­gal bat­tle against com­pound­ing phar­ma­cies, well­ness cen­ters

Fed­er­al judges have blocked two Flori­da well­ness cen­ters from us­ing No­vo Nordisk’s trade­mark to mar­ket com­pound­ed drugs con­tain­ing its di­a­betes and weight loss block­buster semaglu­tide …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.